Sarasin & Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Other funds holding TMO
Sarasin & Partners's TMO Position: Q3 2026 in Review
Sarasin & Partners reduced its Thermo Fisher Scientific (TMO) stake by 3.7% in Q3 2026, selling an estimated $5.87M and leaving 256,996 shares worth $173M. The position accounts for 1.94% of the portfolio, ranked #19.
Sarasin & Partners first reported a position in TMO in Q1 2022 and has held it in 18 quarters since. The position peaked at $310M in Q2 2024. 2,772 funds tracked by Wall St. Rank hold TMO as of Q3 2026.
- Sarasin & Partners held 256,996 shares of Thermo Fisher Scientific worth $173M as of Q3 2026.
- Sarasin & Partners sold 9,876 Thermo Fisher Scientific shares in Q3 2026, an estimated $5.87M.
- Thermo Fisher Scientific made up 1.94% of Sarasin & Partners's portfolio in Q3 2026, its #19 holding.
- Sarasin & Partners first reported a position in Thermo Fisher Scientific in Q1 2022 and has held it in 18 quarters since.
- Sarasin & Partners's Thermo Fisher Scientific position peaked at $310M in Q2 2024.
- 2,772 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.
Based on Sarasin & Partners's 13F filing for Q3 2026, filed 13 Oct 2026.